Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclin dependent kinase inhibitors and methods of use

Cyclin dependent kinase inhibitors and methods of use

US Patent 9616062 · Granted Apr 11, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic targeting of KMT2D mutant lung squamous cell carcinoma through RTK-R2025
Treatment of Rb-negative tumors using topoisomerase inhibitors in combination wi2025
Combination therapy for treatment of LKB1 deficient cancers2024
Compositions and methods of modulating anti-tumor immunity2024
Transient protection of normal cells during chemotherapy2023
HSPC-sparing treatments for RB-positive abnormal cellular proliferation2023
Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint in2023
Preservation of immune response during chemotherapy regimens2022
Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compound2022
Combination therapy for cancer using bromodomain and extra-terminal (BET) protei2022
Methods of use and pharmaceutical combinations of HDAC inhibitors with BET inhib2022
EZH2 inhibitors and uses thereof2022